Dr. Jeffrey David Seip, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 57402 29 Palms Hwy Ste 5, Yucca Valley, CA 92284 Phone: 760-365-2520 Fax: 760-365-2524 |
News Archive
NicOx S.A. today announced that a New Drug Application (NDA) for naproxcinod has been submitted to the United States Food and Drug Administration (FDA), seeking approval for an indication for the relief of the signs and symptoms of osteoarthritis (OA). The NDA file contains data from three large pivotal phase 3 studies, all of which met their co-primary efficacy endpoints. NicOx plans to submit a Marketing Authorization Application (MAA) for naproxcinod to the European Medicines Agency (EMEA) in Q4 2009.
The Elizabeth Glaser Pediatric AIDS Foundation today announced that it will join the Population Council and a prestigious consortium of leading HIV research organizations as part of a five-year project funded by the U.S. Agency for International Development. The Supporting Operational AIDS Research project aims to conduct operational HIV and AIDS research, promote utilization and dissemination of data, and build the capacity of local organizations to conduct operational research.
The addition of changes in inflammatory biomarkers to established clinical variables improves the prediction of mortality in patients with chronic obstructive pulmonary disease (COPD), according to a new study.
For the first time, research led by Youming Lu, PhD, MD, Professor of Neurology and Neuroscience at LSU Health Sciences Center New Orleans School of Medicine, has identified a novel mechanism that may trigger brain damage during stroke and identified a therapeutic approach to block it.
Why does inhaling anesthetics cause unconsciousness? New insights into this century-and-a-half-old question may spring from research performed at the National Institute of Standards and Technology.
› Verified 1 days ago